Biosimilar Newsletter Archive

61. 02.20.25 -- Using Simple Spreadsheet DoE To Optimize The Protein Pipeline 2/20/2025
    02/20/25 Biosimilar Development Newsletter
62. 02.13.25 -- Using Simple Spreadsheet DoE To Optimize The Protein Pipeline 2/13/2025
    02/13/25 Biosimilar Development Newsletter
63. 02.06.25 -- Developing ADCs? A Refresher On HPAPI Occupational Health Risk Mitigation 2/6/2025
    02/06/25 Biosimilar Development Newsletter
64. 01.30.25 -- New Regulatory Survey Findings: Biotech Market Access Challenges 1/30/2025
    01/30/25 Biosimilar Development Newsletter
65. 01.23.25 -- How To Establish A Win-Win Relationship With Your CDMO 1/23/2025
    01/23/25 Biosimilar Development Newsletter
66. 01.16.25 -- Become A cGMP "Special Agent" With A License To Care 1/16/2025
    01/16/25 Biosimilar Development Newsletter
67. 01.09.25 -- AP Biosciences' Approach To Complex Antibody Manufacturing 1/9/2025
    01/09/25 Biosimilar Development Newsletter
68. 01.02.25 -- Cell Culture Trends To Watch In 2025 1/2/2025
    01/02/25 Biosimilar Development Newsletter
69. 12.19.24 -- How To Ensure 21 CFR Part 11 Compliance 12/19/2024

    12/19/24 Biosimilar Development Newsletter

70. 12.19.24 -- 4 Technologies To Transform The Supply Chain in 2025 12/19/2024
    12/19/24 Biosimilar Development Newsletter